Douglas S Goodin. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Clinical Trials as TopicData Interpretation, StatisticalHumansInterferon-beta/therapeutic useMultiple Sclerosis, Relapsing-Remitting/diagnosisMultiple Sclerosis, Relapsing-Remitting/drug therapyPatient ComplianceResearch DesignTreatment Outcome
Substances: See more » Interferon-beta
Year: 2003 PMID: 12781556 DOI: 10.1016/S0140-6736(03)13416-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321